返回 Agenda
Walking the Talk: What Happens When Clinical Trialists Join Clinical Trials?
Session Chair(s)
Jane Myles, MSC
Program Director
Jemtech Co, United States
In this forum we share experiences as volunteers in Phase 3 COVID-19 vaccine trials. Few of us enroll in trials, even though our work is designing, executing, and analyzing clinical trials. This is a way to learn through our participation.
Learning Objective : Discuss stories of participating in a COVID-19 vaccine trial as a healthy volunteer; Evaluate insights on the patient experience in the trial, and the key takeaways as a clinical trialist that are made clear by participation; Identify potential options for a different patient experience in future trials that leverage technology and other patient-centric trial solutions.
Speaker(s)
Panelist
Kelly Johnston McKee, MS
Evinova, An Astrazeneca Company, United States
Head of Innovative Patient Recruitment
Panelist
Angela Radcliffe
Bristol-Myers Squibb Company , United States
Head, Data Governance and Stewardship
Panelist
Craig Serra, MBA, MS
Flatiron Health, United States
Head of Commercial Solutions and Partnerships